Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Predicting non-sentinel lymph node status after positive sentinel biopsy in breast cancer: what model performs the best in a Czech population?

O. Coufal, T. Pavlík, P. Fabian, R. Bori, G. Boross, I. Sejben, R. Maráz, J. Koča, E. Krejčí, I. Horáková, V. Foltinová, P. Vrtělová, V. Chrenko, Tekle W Eliza, M. Rajtar, M. Svebis, V. Fait, G. Cserni

. 2009 ; 15 (4) : 733-740.

Jazyk angličtina Země Nizozemsko

Typ dokumentu srovnávací studie

Perzistentní odkaz   https://www.medvik.cz/link/bmc12009127

Several models have previously been proposed to predict the probability of non-sentinel lymph node (NSLN) metastases after a positive sentinel lymph node (SLN) biopsy in breast cancer. The aim of this study was to assess the accuracy of two previously published nomograms (MSKCC, Stanford) and to develop an alternative model with the best predictive accuracy in a Czech population. In the basic population of 330 SLN-positive patients from the Czech Republic, the accuracy of the MSKCC and the Stanford nomograms was tested by the area under the receiver operating characteristics curve (AUC). A new model (MOU nomogram) was proposed according to the results of multivariate analysis of relevant clinicopathologic variables. The new model was validated in an independent test population from Hungary (383 patients). In the basic population, six of 27 patients with isolated tumor cells (ITC) in the SLN harbored additional NSLN metastases. The AUCs of the MSKCC and Stanford nomograms were 0.68 and 0.66, respectively; for the MOU nomogram it reached 0.76. In the test population, the AUC of the MOU nomogram was similar to that of the basic population (0.74). The presence of only ITC in SLN does not preclude further nodal involvement. Additional variables are beneficial when considering the probability of NSLN metastases. In the basic population, the previously published nomograms (MSKCC and Stanford) showed only limited accuracy. The developed MOU nomogram proved more suitable for the basic population, such as for another independent population from a mid-European country.

Citace poskytuje Crossref.org

000      
03661naa a2200601 a 4500
001      
bmc12009127
003      
CZ-PrNML
005      
20130730101144.0
008      
120319s2009 ne eng||
009      
AR
024    __
$a 10.1007/s12253-009-9177-6 $2 doi
035    __
$a (PubMed)19440855
040    __
$d ABA008 $a ABA008 $b cze
041    0_
$a eng
044    __
$a ne
100    1_
$a Coufal, Oldřich $7 xx0073748 $u Department of Surgical Oncology, Masaryk Memorial Cancer Institute, Zluty kopec, Brno
245    10
$a Predicting non-sentinel lymph node status after positive sentinel biopsy in breast cancer: what model performs the best in a Czech population? / $c O. Coufal, T. Pavlík, P. Fabian, R. Bori, G. Boross, I. Sejben, R. Maráz, J. Koča, E. Krejčí, I. Horáková, V. Foltinová, P. Vrtělová, V. Chrenko, Tekle W Eliza, M. Rajtar, M. Svebis, V. Fait, G. Cserni
520    9_
$a Several models have previously been proposed to predict the probability of non-sentinel lymph node (NSLN) metastases after a positive sentinel lymph node (SLN) biopsy in breast cancer. The aim of this study was to assess the accuracy of two previously published nomograms (MSKCC, Stanford) and to develop an alternative model with the best predictive accuracy in a Czech population. In the basic population of 330 SLN-positive patients from the Czech Republic, the accuracy of the MSKCC and the Stanford nomograms was tested by the area under the receiver operating characteristics curve (AUC). A new model (MOU nomogram) was proposed according to the results of multivariate analysis of relevant clinicopathologic variables. The new model was validated in an independent test population from Hungary (383 patients). In the basic population, six of 27 patients with isolated tumor cells (ITC) in the SLN harbored additional NSLN metastases. The AUCs of the MSKCC and Stanford nomograms were 0.68 and 0.66, respectively; for the MOU nomogram it reached 0.76. In the test population, the AUC of the MOU nomogram was similar to that of the basic population (0.74). The presence of only ITC in SLN does not preclude further nodal involvement. Additional variables are beneficial when considering the probability of NSLN metastases. In the basic population, the previously published nomograms (MSKCC and Stanford) showed only limited accuracy. The developed MOU nomogram proved more suitable for the basic population, such as for another independent population from a mid-European country.
590    __
$a bohemika - dle Pubmed
650    02
$a dospělí $7 D000328
650    02
$a senioři $7 D000368
650    02
$a senioři nad 80 let $7 D000369
650    02
$a algoritmy $7 D000465
650    02
$a nádory prsu $x etnologie $x patologie $7 D001943
650    02
$a ženské pohlaví $7 D005260
650    02
$a lidé $7 D006801
650    02
$a lymfatické metastázy $x diagnóza $x patologie $7 D008207
650    02
$a lidé středního věku $7 D008875
650    02
$a nomogramy $7 D049451
650    02
$a prediktivní hodnota testů $7 D011237
650    02
$a ROC křivka $7 D012372
650    02
$a biopsie sentinelové lymfatické uzliny $7 D021701
651    _2
$a Česká republika $7 D018153
655    _2
$a srovnávací studie $7 D003160
700    1_
$a Pavlík, Tomáš $7 xx0093293
700    1_
$a Fabian, Pavel $7 xx0041823
700    1_
$a Bori, Rita
700    1_
$a Boross, Gábor
700    1_
$a Sejben, István
700    1_
$a Maráz, Róbert
700    1_
$a Koča, Jaroslav, $d 1955-2021 $7 jn20000710314
700    1_
$a Krejčí, Eva $7 xx0061138
700    1_
$a Horáková, Iva $7 xx0164162
700    1_
$a Foltinová, Vendula. $7 xx0241084
700    1_
$a Vrtělová, Pavlína $7 xx0169222
700    1_
$a Chrenko, Vojtěch, $d 1950- $7 xx0061125
700    1_
$a Tekle, Eliza Wolde
700    1_
$a Rajtár, Maria
700    1_
$a Svébis, Mihaly
700    1_
$a Fait, Vuk $7 xx0053339
700    1_
$a Cserni, Gabor
773    0_
$t Pathology Oncology Research $p Pathol Oncol Res $g Roč. 15, č. 4 (2009), s. 733-740 $x def $w MED00180530
773    0_
$p Pathol Oncol Res $g 15(4):733-40, 2009 Dec
910    __
$a ABA008 $b x $y 4
990    __
$a 20120319150847 $b ABA008
991    __
$a 20130730101640 $b ABA008
999    __
$a ok $b bmc $g 902351 $s 766033
BAS    __
$a 3
BMC    __
$a 2009 $b 15 $c 4 $d 733-740 $i def $m Pathology oncology research $x MED00180530
LZP    __
$a 2012-1Q10/

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...